{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:35:22Z","timestamp":1789918522654,"version":"4.0.1"},"reference-count":110,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":170,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lymphadenopathies can be part of the clinical spectrum of several primary immunodeficiencies, including diseases with immune dysregulation and autoinflammatory disorders, as the clinical expression of benign polyclonal lymphoproliferation, granulomatous disease or lymphoid malignancy. Lymphadenopathy poses a significant diagnostic dilemma when it represents the first sign of a disorder of the immune system, leading to a consequently delayed diagnosis. Additionally, the finding of lymphadenopathy in a patient with diagnosed immunodeficiency raises the question of the differential diagnosis between benign lymphoproliferation and malignancies. Lymphadenopathies are evidenced in 15\u201320% of the patients with common variable immunodeficiency, while in other antibody deficiencies the prevalence is lower. They are also evidenced in different combined immunodeficiency disorders, including Omenn syndrome, which presents in the first months of life. Interestingly, in the activated phosphoinositide 3-kinase delta syndrome, autoimmune lymphoproliferative syndrome, Epstein\u2013Barr virus (EBV)-related lymphoproliferative disorders and regulatory T cell disorders, lymphadenopathy is one of the leading signs of the entire clinical picture. Among autoinflammatory diseases, the highest prevalence of lymphadenopathies is observed in patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) and hyper-immunoglobulin (Ig)D syndrome. The mechanisms underlying lymphoproliferation in the different disorders of the immune system are multiple and not completely elucidated. The advances in genetic techniques provide the opportunity of identifying new monogenic disorders, allowing genotype\u2013phenotype correlations to be made and to provide adequate follow-up and treatment in the single diseases. In this work, we provide an overview of the most relevant immune disorders associated with lymphadenopathy, focusing on their diagnostic and prognostic implications.<\/jats:p>","DOI":"10.1111\/cei.13620","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:01:21Z","timestamp":1621382481000},"page":"288-305","source":"Crossref","is-referenced-by-count":31,"title":["Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge"],"prefix":"10.1093","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-3727","authenticated-orcid":false,"given":"Giorgio","family":"Costagliola","sequence":"first","affiliation":[{"name":"Section of Clinical and Laboratory Immunology, Division of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5968-1945","authenticated-orcid":false,"given":"Rita","family":"Consolini","sequence":"additional","affiliation":[{"name":"Section of Clinical and Laboratory Immunology, Division of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,20]]},"reference":[{"key":"2021121100023689600_cei13620-bib-0001","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pcl.2016.08.007","article-title":"Immunodeficiency presenting as an undiagnosed disease","volume":"64","author":"Routes","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"2021121100023689600_cei13620-bib-0002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fimmu.2019.00586","article-title":"Primary and secondary immunodeficiency diseases in oncohaematology: warning signs, diagnosis, and management","volume":"10","author":"S\u00e1nchez-Ram\u00f3n","year":"2019","journal-title":"Front Immunol"},{"key":"2021121100023689600_cei13620-bib-0003","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fimmu.2019.00777","article-title":"A systematic review on predisposition to lymphoid (B and T cell) neoplasias in patients with primary immunodeficiencies and immune dysregulatory disorders (inborn errors of immunity)","volume":"10","author":"Riaz","year":"2019","journal-title":"Front Immunol"},{"key":"2021121100023689600_cei13620-bib-0004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS phenotypic classification for primary immunodeficiencies","volume":"38","author":"Bousfiha","year":"2018","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0005","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaci.2016.08.003","article-title":"Exome and genome sequencing for inborn errors of immunity","volume":"138","author":"Meyts","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0006","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fimmu.2014.00415","article-title":"Comparison of diagnostic criteria for common variable immunodeficiency disorder","volume":"5","author":"Ameratunga","year":"2014","journal-title":"Front Immunol"},{"key":"2021121100023689600_cei13620-bib-0007","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","article-title":"Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis","volume":"11","author":"Ho","year":"2020","journal-title":"Front Immunol"},{"key":"2021121100023689600_cei13620-bib-0008","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11882-016-0597-6","article-title":"Autoimmune and lymphoproliferative complications of common variable immunodeficiency","volume":"16","author":"Maglione","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"2021121100023689600_cei13620-bib-0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"2021121100023689600_cei13620-bib-0011","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s10875-020-00769-8","article-title":"Lymphoproliferative disease in CVID: a report of types and frequencies from a US patient registry","volume":"40","author":"Yakaboski","year":"2020","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0012","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"2021121100023689600_cei13620-bib-0013","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103690","article-title":"Genes associated with common variable immunodeficiency: one diagnosis to rule them all?","volume":"53","author":"Bogaert","year":"2016","journal-title":"J Med Genet"},{"key":"2021121100023689600_cei13620-bib-0014","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3389\/fimmu.2019.03022","article-title":"Identification of novel genetic variants in CVID patients with autoimmunity, autoinflammation, or malignancy","volume":"10","author":"Christiansen","year":"2019","journal-title":"Front Immunol"},{"key":"2021121100023689600_cei13620-bib-0015","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"Loss-of-function nuclear factor \u03baB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans","volume":"142","author":"Tuijnenburg","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0016","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clim.2009.05.001","article-title":"Granulomatous disease in common variable immunodeficiency","volume":"133","author":"Ardeniz","year":"2009","journal-title":"Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0017","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2021121100023689600_cei13620-bib-0018","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2008.02.013","article-title":"Memory B cells in common variable immunodeficiency: clinical associations and sex differences","volume":"128","author":"S\u00e1nchez-Ram\u00f3n","year":"2008","journal-title":"Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0019","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/1744666X.2019.1658523","article-title":"Malignancy in common variable immunodeficiency: a systematic review and meta-analysis","volume":"15","author":"Kiaee","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0020","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.2019002062","article-title":"Common variable immune deficiency: case studies","volume":"134","author":"Cunningham-Rundles","year":"2019","journal-title":"Blood"},{"key":"2021121100023689600_cei13620-bib-0021","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s10875-011-9565-z","article-title":"Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events","volume":"31","author":"da Silva","year":"2011","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0022","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"2021121100023689600_cei13620-bib-0023","article-title":"Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency","author":"Verbsky","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2019.05.001","article-title":"Comparison of clinical and immunological features and mortality in common variable immunodeficiency and agammaglobulinemia patients","volume":"210","author":"Bagheri","year":"2019","journal-title":"Immunol Lett"},{"key":"2021121100023689600_cei13620-bib-0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2017.07.008","article-title":"X-linked agammaglobulinaemia: outcomes in the modern era","volume":"183","author":"Shillitoe","year":"2017","journal-title":"Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0026","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s10875-013-9971-5","article-title":"Gastric adenocarcinoma in the context of X-linked agammaglobulinemia: case report and review of the literature","volume":"34","author":"Staines Boone","year":"2014","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0027","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.dnarep.2006.10.014","article-title":"Uracil in DNA \u2013 general mutagen, but normal intermediate in acquired immunity","volume":"6","author":"Kavli","year":"2007","journal-title":"DNA Repair"},{"key":"2021121100023689600_cei13620-bib-0028","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11926-019-0854-5","article-title":"Novel developments in primary immunodeficiencies (PID) \u2013 a rheumatological perspective","volume":"21","author":"Leavis","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"2021121100023689600_cei13620-bib-0029","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nri.2016.28","article-title":"Human RAG mutations: biochemistry and clinical implications","volume":"16","author":"Notarangelo","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2021121100023689600_cei13620-bib-0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/nyas.12849","article-title":"Severe combined immunodeficiency\u2013an update","volume":"1356","author":"Cirillo","year":"2015","journal-title":"Ann NY Acad Sci"},{"key":"2021121100023689600_cei13620-bib-0031","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s004310100816","article-title":"Reviewing Omenn syndrome","volume":"160","author":"Aleman","year":"2001","journal-title":"Eur J Pediatr"},{"key":"2021121100023689600_cei13620-bib-0032","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front Pediatr"},{"key":"2021121100023689600_cei13620-bib-0033","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/imr.12713","article-title":"RAG gene defects at the verge of immunodeficiency and immune dysregulation","volume":"287","author":"Villa","year":"2019","journal-title":"Immunol Rev"},{"key":"2021121100023689600_cei13620-bib-0034","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa073966","article-title":"An immunodeficiency disease with RAG mutations and granulomas","volume":"358","author":"Schuetz","year":"2008","journal-title":"N Engl J Med"},{"key":"2021121100023689600_cei13620-bib-0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/cid\/ciw675","article-title":"Cutaneous and visceral chronic granulomatous disease triggered by a rubella virus vaccine strain in children with primary immunodeficiencies","volume":"64","author":"Neven","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2021121100023689600_cei13620-bib-0036","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaci.2018.05.028","article-title":"PROMIDIS\u03b1: a T-cell receptor \u03b1 signature associated with immunodeficiencies caused by V(D)J recombination defects","volume":"143","author":"Berland","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0037","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaci.2014.06.015","article-title":"The CARD11-BCL10-MALT1 (CBM) signalosome complex: stepping into the limelight of human primary immunodeficiency","volume":"134","author":"Turvey","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0038","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3389\/fimmu.2017.00913","article-title":"Intrinsic plasma cell differentiation defects in B cell expansion with NF-\u03baB and T Cell anergy patient B cells","volume":"8","author":"Arjunaraja","year":"2017","journal-title":"Front Immunol"},{"key":"2021121100023689600_cei13620-bib-0039","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.20182304","article-title":"Human interleukin-2 receptor \u03b2 mutations associated with defects in immunity and peripheral tolerance","volume":"216","author":"Zhang","year":"2019","journal-title":"J Exp Med"},{"key":"2021121100023689600_cei13620-bib-0040","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192275","article-title":"NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation","volume":"217","author":"Castro","year":"2020","journal-title":"J Exp Med"},{"key":"2021121100023689600_cei13620-bib-0041","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gendis.2019.09.015","article-title":"An updated review on activated PI3 kinase delta syndrome (APDS)","volume":"7","author":"Singh","year":"2020","journal-title":"Genes Dis"},{"key":"2021121100023689600_cei13620-bib-0042","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jaci.2019.03.017","article-title":"PI3K pathway defects leading to immunodeficiency and immune dysregulation","volume":"143","author":"Nunes-Santos","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0043","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: A large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0044","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nri.2016.93","article-title":"PI3K\u03b4 and primary immunodeficiencies","volume":"16","author":"Lucas","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2021121100023689600_cei13620-bib-0045","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.3390\/jcm9103335","article-title":"Activated phosphoinositide 3-kinase delta syndrome 1: clinical and immunological data from an Italian cohort of patients","volume":"9","author":"Tessarin","year":"2020","journal-title":"J Clin Med"},{"key":"2021121100023689600_cei13620-bib-0046","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tranon.2018.11.003","article-title":"PTEN hamartoma tumor syndrome and immune dysregulation","volume":"12","author":"Eissing","year":"2019","journal-title":"Transl Oncol"},{"key":"2021121100023689600_cei13620-bib-0047","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1093\/jpids\/piy014","article-title":"Noninfectious manifestations and complications of chronic granulomatous disease","volume":"7","author":"Henrickson","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2021121100023689600_cei13620-bib-0048","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2141.2003.04310.x","article-title":"High incidence of lymphomas in a subgroup of Wiskott\u2013Aldrich syndrome patients","volume":"121","author":"Shcherbina","year":"2003","journal-title":"Br J Haematol"},{"key":"2021121100023689600_cei13620-bib-0049","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-7-13","article-title":"Nijmegen breakage syndrome (NBS)","volume":"7","author":"Chrzanowska","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"2021121100023689600_cei13620-bib-0050","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/ijd.12408","article-title":"Bloom syndrome","volume":"53","author":"Arora","year":"2014","journal-title":"Int J Dermatol"},{"key":"2021121100023689600_cei13620-bib-0051","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a Review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"2021121100023689600_cei13620-bib-0052","doi-asserted-by":"crossref","first-page":"e12913","DOI":"10.1111\/sji.12913","article-title":"Immunodeficiency in cartilage-hair hypoplasia: Pathogenesis, clinical course and management","volume":"92","author":"Vakkilainen","year":"2020","journal-title":"Scand J Immunol"},{"key":"2021121100023689600_cei13620-bib-0053","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood-2014-11-567917","article-title":"JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities","volume":"125","author":"Calvo","year":"2015","journal-title":"Blood"},{"key":"2021121100023689600_cei13620-bib-0054","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10875-020-00883-7","article-title":"Clinical spectrum of ras-associated autoimmune leukoproliferative disorder (RALD)","volume":"41","author":"Neven","year":"2021","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5858\/arpa.2018-0190-RS","article-title":"Autoimmune lymphoproliferative syndrome: an overview","volume":"144","author":"Matson","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"2021121100023689600_cei13620-bib-0056","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.12688\/f1000research.11545.1","article-title":"Autoimmune lymphoproliferative syndrome: more than a FAScinating disease","volume":"6","author":"Bride","year":"2017","journal-title":"F1000Res"},{"key":"2021121100023689600_cei13620-bib-0057","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1182\/blood.2020005486","article-title":"Key diagnostic markers for autoimmune lymphoproliferative syndrome with molecular genetic diagnosis","volume":"136","author":"Moln\u00e1r","year":"2020","journal-title":"Blood"},{"key":"2021121100023689600_cei13620-bib-0058","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)65742-2","article-title":"Pathological findings in human autoimmune lymphoproliferative syndrome","volume":"153","author":"Lim","year":"1998","journal-title":"Am J Pathol"},{"key":"2021121100023689600_cei13620-bib-0059","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"key":"2021121100023689600_cei13620-bib-0060","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1182\/blood.2020005844","article-title":"Germline TET2 loss of function causes childhood immunodeficiency and lymphoma","volume":"136","author":"Stremenova Spegarova","year":"2020","journal-title":"Blood"},{"key":"2021121100023689600_cei13620-bib-0061","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10875-016-0323-0","article-title":"Protein kinase C \u03b4: a gatekeeper of immune homeostasis","volume":"36","author":"Salzer","year":"2016","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0062","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12016-015-8466-y","article-title":"Updated understanding of autoimmune lymphoproliferative syndrome (ALPS)","volume":"50","author":"Li","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"2021121100023689600_cei13620-bib-0063","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jaci.2018.10.026","article-title":"Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency","volume":"142","author":"Cepika","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0064","doi-asserted-by":"crossref","first-page":"102526","DOI":"10.1016\/j.autrev.2020.102526","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: a systematic Review","volume":"19","author":"Park","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2021121100023689600_cei13620-bib-0065","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3389\/fimmu.2018.02411","article-title":"Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"9","author":"Gambineri","year":"2018","journal-title":"Front Immunol"},{"key":"2021121100023689600_cei13620-bib-0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12997","article-title":"Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations","volume":"190","author":"Verma","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"2021121100023689600_cei13620-bib-0067","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0068","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10875-015-0224-7","article-title":"Spectrum of Phenotypes Associated with Mutations in LRBA","volume":"36","author":"Alkhairy","year":"2016","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0069","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s10875-019-00677-6","article-title":"A spectrum of clinical findings from ALPS to CVID: several novel LRBA defects","volume":"39","author":"Cagdas","year":"2019","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0070","doi-asserted-by":"crossref","DOI":"10.1111\/cei.13600","article-title":"Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic Review","author":"Jamee","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"2021121100023689600_cei13620-bib-0071","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clim.2013.01.004","article-title":"Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0072","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jaci.2006.10.007","article-title":"CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes","volume":"119","author":"Caudy","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0073","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/ni.3753","article-title":"BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency","volume":"18","author":"Afzali","year":"2017","journal-title":"Nat Immunol"},{"key":"2021121100023689600_cei13620-bib-0074","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1189\/jlb.5RI0516-237RR","article-title":"STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases","volume":"101","author":"Lorenzini","year":"2017","journal-title":"J Leukoc Biol"},{"key":"2021121100023689600_cei13620-bib-0075","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"2021121100023689600_cei13620-bib-0076","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clim.2017.05.021","article-title":"STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds","volume":"181","author":"Nabhani","year":"2017","journal-title":"Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0077","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 Gain-of-function germline mutations: a systematic Review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2021121100023689600_cei13620-bib-0078","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"2021121100023689600_cei13620-bib-0079","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fped.2019.00160","article-title":"Gain-of-function STAT1 mutation with familial lymphadenopathy and Hodgkin lymphoma","volume":"7","author":"Henrickson","year":"2019","journal-title":"Front Pediatr"},{"key":"2021121100023689600_cei13620-bib-0080","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-020-18925-4","article-title":"Early-onset autoimmunity associated with SOCS1 haploinsufficiency","volume":"11","author":"Hadjadj","year":"2020","journal-title":"Nat Commun"},{"key":"2021121100023689600_cei13620-bib-0081","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fped.2019.00353","article-title":"Inborn errors of immunity with immune dysregulation: from bench to bedside","volume":"7","author":"Delmonte","year":"2019","journal-title":"Front Pediatr"},{"key":"2021121100023689600_cei13620-bib-0082","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Autoimmune Disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"2021121100023689600_cei13620-bib-0083","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2217\/fmb.12.147","article-title":"Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis","volume":"8","author":"Saha","year":"2013","journal-title":"Future Microbiol"},{"key":"2021121100023689600_cei13620-bib-0084","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/imr.12791","article-title":"Signaling pathways involved in the T-cell-mediated immunity against Epstein\u2013Barr virus: lessons from genetic diseases","volume":"291","author":"Latour","year":"2019","journal-title":"Immunol Rev"},{"key":"2021121100023689600_cei13620-bib-0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI131116","article-title":"Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease","volume":"130","author":"Ravell","year":"2020","journal-title":"J Clin Invest"},{"key":"2021121100023689600_cei13620-bib-0086","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10875-018-0533-8","article-title":"Novel mutations in RASGRP1 are associated with immunodeficiency, immune dysregulation, and EBV-induced lymphoma","volume":"38","author":"Somekh","year":"2018","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0087","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2019.03.002","article-title":"Immunodeficiency and EBV-induced lymphoproliferation caused by 4\u20131BB deficiency","volume":"144","author":"Alosaimi","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0088","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3389\/fimmu.2018.02400","article-title":"EBV negative lymphoma and autoimmune lymphoproliferative syndrome like phenotype extend the clinical spectrum of primary immunodeficiency caused by STK4 deficiency","volume":"9","author":"Schipp","year":"2018","journal-title":"Front Immunol"},{"key":"2021121100023689600_cei13620-bib-0089","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nature13386","article-title":"CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation","volume":"510","author":"Martin","year":"2014","journal-title":"Nature"},{"key":"2021121100023689600_cei13620-bib-0090","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fimmu.2018.00979","article-title":"Interleukin-2-inducible T-cell kinase deficiency-new patients, new insight?","volume":"9","author":"Ghosh","year":"2018","journal-title":"Front Immunol"},{"key":"2021121100023689600_cei13620-bib-0091","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.20160784","article-title":"Inherited CD70 deficiency in humans reveals a critical role for the CD70\u2013CD27 pathway in immunity to Epstein\u2013Barr virus infection","volume":"214","author":"Izawa","year":"2017","journal-title":"J Exp Med"},{"key":"2021121100023689600_cei13620-bib-0092","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jaci.2015.02.022","article-title":"Novel mutations in TNFRSF7\/CD27: clinical, immunologic, and genetic characterization of human CD27 deficiency","volume":"136","author":"Alkhairy","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0093","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1182\/blood.2020006738","article-title":"Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency","volume":"136","author":"Ghosh","year":"2020","journal-title":"Blood"},{"key":"2021121100023689600_cei13620-bib-0094","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10875-020-00790-x","article-title":"An update on XMEN disease","volume":"40","author":"Ravell","year":"2020","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-62703-357-2_16","article-title":"EBER in situ hybridization for Epstein\u2013Barr virus","volume":"999","author":"Weiss","year":"2013","journal-title":"Methods Mol Biol"},{"key":"2021121100023689600_cei13620-bib-0096","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s10875-014-0083-7","article-title":"XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP","volume":"34","author":"Tangye","year":"2014","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0097","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10875-016-0317-y","article-title":"Fatal lymphoproliferative disease in two siblings lacking functional FAAP24","volume":"36","author":"Daschkey","year":"2016","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0098","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10875-015-0141-9","article-title":"X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome","volume":"35","author":"Aguilar","year":"2015","journal-title":"J Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0099","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clim.2018.12.016","article-title":"Management of XLP-1 and ITK deficiency: The challenges posed by PID with an unpredictable spectrum of disease manifestations","volume":"198","author":"Shadur","year":"2019","journal-title":"Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0100","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2011.02.047","article-title":"Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies","volume":"127","author":"Rezaei","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100023689600_cei13620-bib-0101","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021121100023689600_cei13620-bib-0102","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.3390\/ijms21093263","article-title":"Revisiting TNF receptor-associated periodic syndrome (TRAPS): current perspectives","volume":"21","author":"Cudrici","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2021121100023689600_cei13620-bib-0103","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s10067-017-3715-5","article-title":"Familial Mediterranean fever, review of the literature","volume":"36","author":"Alghamdi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2021121100023689600_cei13620-bib-0104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1546-0096-12-33","article-title":"Blau syndrome, the prototypic auto-inflammatory granulomatous disease","volume":"12","author":"Wouters","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"2021121100023689600_cei13620-bib-0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12969-016-0111-7","article-title":"Monogenic polyarteritis: the lesson of ADA2 deficiency","volume":"14","author":"Caorsi","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"2021121100023689600_cei13620-bib-0106","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00296-019-04257-0","article-title":"Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: main features and an algorithm for clinical practice","volume":"39","author":"Batu","year":"2019","journal-title":"Rheumatol Int"},{"key":"2021121100023689600_cei13620-bib-0107","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/TACG.S93933","article-title":"Mevalonate kinase deficiency: current perspectives","volume":"9","author":"Favier","year":"2016","journal-title":"Appl Clin Genet"},{"key":"2021121100023689600_cei13620-bib-0108","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fped.2019.00277","article-title":"Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome (PFAPA): a clinical challenge for primary care physicians and rheumatologists","volume":"7","author":"Costagliola","year":"2019","journal-title":"Front Pediatr"},{"key":"2021121100023689600_cei13620-bib-0109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12969-016-0091-7","article-title":"Natural history of mevalonate kinase deficiency: a literature Review","volume":"14","author":"Zhang","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"2021121100023689600_cei13620-bib-0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1573396315666191114150438","article-title":"Practical approach to children presenting with eosinophila and hypereosinophilia","volume":"16","author":"Costagliola","year":"2020","journal-title":"Curr Pediatr Rev"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13620","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13620","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/205\/3\/288\/41591664\/cei13620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/205\/3\/288\/41591664\/cei13620.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:25:29Z","timestamp":1641036329000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/205\/3\/288\/6431049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,20]]},"references-count":110,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,6,20]]},"published-print":{"date-parts":[[2021,8,18]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13620","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740142729.793589829","asserted-by":"object"}]},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,6,20]]}}}